|Bid||46.22 x 1000|
|Ask||46.22 x 800|
|Day's Range||45.62 - 46.50|
|52 Week Range||44.21 - 68.98|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 7, 2018 - Aug 13, 2018|
|Forward Dividend & Yield||0.35 (0.70%)|
|1y Target Est||67.86|
Alan Valdes, director of floor operations at Silverbear Capital, joins Yahoo Finance's Alexis Christoforous from the floor of the New York Stock Exchange to discuss the latest market moves.
A rapidly changing healthcare environment in the United States, sluggish first quarter, declining margins and foreign exchange headwinds continue to hurt DENTSPLY SIRONA (XRAY).
This Thursday, WallStEquities.com has initiated reports coverage on the following Healthcare equities: ConforMIS Inc. (NASDAQ: CFMS), DENTSPLY SIRONA Inc. (NASDAQ: XRAY), Agilent Technologies Inc. (NYSE: A), and Biocept Inc. (NASDAQ: BIOC). Billerica, Massachusetts headquartered ConforMIS Inc.'s stock finished Wednesday's session 2.19% lower at $1.34 with a total trading volume of 380,145 shares.
The S&P 500’s top gainers on May 10 were: CenturyLink (CTL) gained 7.5%. Discovery Comm (DISCK) gained 6.9%. Discovery Comm A (DISCA) gained 6.9%. Envision Healthcare Holdings (EVHC) gained 5%. Dentsply Sirona (XRAY) gained 4.4%. CenturyLink
Stocks that moved substantially or traded heavily Monday: Athenahealth Inc., up $20.67 to $146.75 Elliott Management is offering about $6.5 billion to take the medical billing software maker private. Exxon ...
Strong performance in Europe and Rest of World boosts DENTAPLY's (XRAY) performance in Q1. However, a lowered guidance indicates looming concerns.
On May 3, Dentsply Sirona (XRAY) closed at $49.24 per share. The stock registered a fall of 2.7% on the day. The stock registered a 52-week low on April 2, when it traded at $48.25. However, it was trading at a 52-week high of $68.98 on November 28, 2017.
On a per-share basis, the York, Pennsylvania-based company said it had profit of 35 cents. Earnings, adjusted for non-recurring costs, came to 45 cents per share. The results exceeded Wall Street expectations. ...
Reported Q1 revenues of $956.1 million, up 6.2% compared to prior year; constant currency growth 1 of negative 1.1% Q1 2018 GAAP EPS of $0.35 with Q1 2018 non-GAAP adjusted EPS of $0.45 Updated 2018 guidance: ...
Let’s talk about the popular DENTSPLY SIRONA Inc (NASDAQ:XRAY). The company’s shares received a lot of attention from a substantial price movement on the NasdaqGS over the last few months,Read More...
Dentsply Sirona (XRAY) will announce its 1Q18 results on May 7. The company has recently made some organizational changes and key management changes. It’s also recently announced its acquisition of OraMetrix to expand its orthodontic treatment solutions portfolio.
Dentsply Sirona (XRAY) accounts for ~0.29% of the total holdings of the Vanguard Mid-Cap ETF (VO). The company is set to release its 1Q18 results on May 7.
Dentsply Sirona (XRAY) is one of the leading dental technology providers in the United States. The company will announce its 1Q18 earnings results on May 7. It’s currently undergoing a restructuring program after failing to realize the expected synergies from its Dentsply International and Sirona Dental Systems merger in February 2016.
DENTSPLY's (XRAY) CAD/CAM unit is likely to drive the top line in Q1. Product innovations and strong R&D prospects are also likely to drive growth.
Align Technology (ALGN) released its 1Q18 earnings results on April 25. The company posted strong sales and earnings that surpassed analyst estimates. The stock rose ~4% after the earnings release. The company also provided guidance for 2Q18 and fiscal 2018 during the earnings release. Several analysts updated their ratings on ALGN stock after the company’s earnings release. In this article, let’s take a look at analysts’ recommendations and target price on ALGN stock for the next 12 months.
Generation Investment Management, of which former Vice President Al Gore serves as chairman, disclosed Thursday that it has taken large stakes in two medical-devices companies. As of April 16, the London-based firm owned 2.5 million shares of Cooper (COO), a 5.2% stake, and 11.8 million shares of Dentsply Sirona (XRAY), also a 5.2% stake. Cooper makes products for contact-lens wearers and offers products and services for women's health.
YORK, Pa., April 25, 2018-- DENTSPLY SIRONA Inc., The Dental Solutions Company TM, announced that its Board of Directors declared a quarterly cash dividend of $0.0875 per share of common stock, an indicated ...
YORK, Pa., April 25, 2018-- DENTSPLY SIRONA Inc., The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Monday, May 7, 2018 at 8:30 am ...
NEW YORK, April 16, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Stock Monitor: Strata Skin Sciences Post Earnings Reporting LONDON, UK / ACCESSWIRE / April 12, 2018 / Active-Investors.com has just released a free earnings report on DENTSPLY SIRONA Inc. (NASDAQ: XRAY ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding XRAY totaled $14.30 billion.
On April 6, 2018, Dentsply Sirona (XRAY) ended at a closing price of $49.02 per share. The stock declined by ~0.14% on the day. XRAY stock was trading at a 52-week high of $68.98 on November 28, 2017. However, the company’s 52-week low came on April 2, 2018, at $48.25. This recent stock price decline was triggered by negative investor sentiments for the company due to recent target price cuts by Wall Street analysts following downward revisions and modelling adjustments in the company’s fiscal 4Q17 earnings release on March 2 and the recent OraMetrix acquisition announcement.
Dentsply Sirona (XRAY), one of the leading dental technology providers in the United States, recently outlined a turnaround plan to recover from the company’s disappointing performance in recent years. This weak performance was due to the lower-than-expected synergies delivered after the merger of Dentsply International and Sirona Dental Systems in February 2016, which led to the formation of Dentsply Sirona. For more detail, read Inside Dentsply Sirona’s New Turnaround Plan.